Breast cancer 3 factors affect NACT mastectomy-sparing benefit

Access to the full content of this site is available only to registered healthcare professionals. Register to read more
  • Neoadjuvant chemotherapy (NACT) reduces mastectomy rates by up to 17% in patients with early breast cancer, depending on tumor stage, receptor subtype, and patient age.
Why this matters
  • Findings help clinicians make informed treatment recommendations on receipt of NACT and its effect o...